The Control Set,blood Chemistry, cataloged under National Stock Number 6550-01-664-2319, is classified within Federal Supply Class 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Ortho-Clinical Diagnostics Inc Dba Ortho-Clinical Diagnostics Inc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6550-01-664-2319 |
| Primary Part Number | 6801421 |
| Item Name | Control Set,blood Chemistry |
| FSC / FSG | 6550 / 65 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Manufacturer | Ortho-Clinical Diagnostics Inc Dba Ortho-Clinical Diagnostics Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| 6801421 PRIMARY | Ortho-Clinical Diagnostics Inc Dba Ortho-Clinical Diagnostics Inc (USA) |
| Reference | Meaning |
|---|---|
| 1462777 | 5/1 Secondary reference U.S. Government activity |
| 6630NCM173599 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6550-01-664-2319 is a Control Set,blood Chemistry, manufactured by Ortho-Clinical Diagnostics Inc Dba Ortho-Clinical Diagnostics Inc, classified under FSC 6550, In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. Status: active.
NSN 6550-01-664-2319 has 1 manufacturer part number on file: 6801421 (Ortho-Clinical Diagnostics Inc Dba Ortho-Clinical Diagnostics Inc).
Key specifications for 6801421: Special Features: ANTI-HCV CONTROLS; FOR USE IN MONITORING THE PERFORMANCE OF THE VITROS ECI/ECIQ IMMUNODIAGNOSTIC SYSTEMS, THE VITROS 3600 IMMUNODIAGNOSTIC SYSTEM AND THE VITROS 5600 INTEGRATED SYSTEM WHEN USED IN THE IN VITRO QUALITATIVE DETECTION OF IMMUNOGLOBULIN G ANTIBODY TO HEPATITIS C VIRUS IN HUMAN SERUM AND PLASMA; CONTAINS 3 SETS OF VITROS ANTI-HCV CONTROLS 1 AND 2; STORE UNOPENED, REFRIGERATED 2 TO 8 C (36 TO 46 F); OPENED RECONSTITUTED REFRIGERATED 2 TO 8 (36 TO 46 F); OPENED RECONSTITUTED FROZEN -20 C ( -4 F); Part Name Assigned by Controlling Agency: CONTROL SET, ANTIBODY HEPATITIS C VIRUS. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.